在阿尔茨海默病中解码NLRP3炎症酶激活:关注受体动力学
Ranika Maurya1, Abha Sharma2, Saba Naqvi3,4
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER-R), Lucknow, UP, 226002, India.
Molecular neurobiology
|April 15, 2025
概括
由NLRP3炎症酶驱动的神经炎症是阿尔茨海默病 (AD) 的关键. 准NLRP3炎症酶通路为AD治疗提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降和神经精神疾病症状.
- 神经炎症,特别是由NLRP3炎症酶介导,在AD病变发生过程中起着至关重要的作用.
- 粉样β斑块和TAU聚合物在AD中充当与损伤相关的分子模式 (DAMPs),激活结质细胞中的NLRP3炎症体.
研究的目的:
- 审查在阿尔茨海默病中NLRP3炎症酶激活的机制.
- 探索TREM-2,MINK1,NF-κB,Toll类受体和P2X7受体在NLRP3调节中的作用.
- 确定调节NLRP3活性以减轻AD中神经炎症的潜在治疗点.
主要方法:
- 文献综述侧重于NLRP3炎症酶激活的分子机制.
- 在AD的背景下,分析涉及TREM-2,MINK1,NF-κB,Toll类受体和P2X7受体的信号通路.
- 综合目前对NLRP3炎症酶在AD病变发生中的作用的理解.
主要成果:
- 在微质和星球细胞中的NLRP3炎症酶激活是由AD相关的DAMPs触发的.
- 激活导致促炎性细胞因子IL-1β和IL-18的释放,加剧神经炎症和神经元死亡.
- 特定的受体和信号通路 (TREM-2,MINK1,NF-κB,TLR,P2X7) 在NLRP3调节中具有复杂的作用.
结论:
- 了解NLRP3炎症酶激活的详细机制,可以深入了解AD病理.
- 准TREM-2,MINK1,NF-κB,TLR和P2X7受体为阿尔茨海默病提供了有前途的治疗途径.
- 调节NLRP3活性可能为减少神经炎症和减缓AD进展提供新的策略.
相关概念视频
01:00Enzyme-linked Receptors
76.3K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.3K
01:31Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K
01:26Alzheimer's Disease: Overview
328
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
328
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K